Polycystic Ovary Syndrome: Exploring the Iceberg of a Lifelong Systemic Disorder

September 2025 in “ Anti-Aging Eastern Europe ”

Plamena Kabakchieva, Simona Bogdanova, Alexander Krasimirov Angelov

polycystic ovary syndrome PCOS hyperandrogenism anovulation polycystic ovarian morphology insulin resistance endocrine disorder

TLDR PCOS requires comprehensive, lifelong care addressing both visible and hidden health issues.

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting women throughout their reproductive lives. While the visible symptoms include hyperandrogenism, anovulation, and polycystic ovarian morphology, the condition's true burden lies in its hidden systemic and psychosocial complexities. These include metabolic issues like insulin resistance and increased cardiometabolic risk, as well as psychological challenges such as depression and anxiety. The review emphasizes that these aspects are often overlooked, leading to delayed diagnosis and unmet patient needs. It calls for a shift towards a holistic, individualized approach to care that addresses both the visible and hidden dimensions of PCOS, advocating for compassionate, interdisciplinary, and lifelong management.

View this study on antiagingeeu.com →

Discuss this study in the Community →

Research cited in this study

8 / 8 results

research Polycystic Ovary Syndrome: Diverse Clinical Presentations Across Adolescence, Reproductive Age, and Menopause

2 citations , June 2024 in “Anti-Aging Eastern Europe”

PCOS symptoms vary by age, affecting diagnosis and treatment.

research Polycystic Ovary Syndrome and the Risk of Obstructive Sleep Apnea: A Meta-Analysis and Review of the Literature

62 citations , July 2017 in “Endocrine connections”

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

research Polycystic Ovarian Syndrome: Long-Term Health Consequences

34 citations , May 2017 in “Seminars in Reproductive Medicine”

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

research The Prevalence and Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

767 citations , September 2016 in “Human Reproduction”

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

research Genetic, Hormonal, and Metabolic Aspects of PCOS: An Update

258 citations , July 2016 in “Reproductive Biology and Endocrinology”

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

research Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

22 citations , January 2012 in “Obstetrics and Gynecology International”

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1744 citations , August 2006 in “The Journal of Clinical Endocrinology and Metabolism”

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , December 2003 in “Human Reproduction”

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.